Aerolase 650-microsecond devices are quickly becoming the foundation therapy for several of the most common and challenging dermatologic conditions due to their safety, efficacy, and tolerability. This new therapy allows physicians to take control of their patients’ outcomes by relying less on prescriptions and capitalizing on in-office treatments that drive new revenues into their business. Learn how expert dermatologist, Mark Nestor, MD, PhD and Julie Santos PA-C use a 650-microsecond device as first-line therapy for these challenging disease states.
Agenda:
The current climate of the acne and psoriasis disease states
Acne: Addressing the pathogenesis of acne by reducing sebum production, suppressing inflammation, and killing p. acnes bacteria with a single device
Psoriasis: Suppressing the inflammation causing the proliferation of keratinocytes and
coagulating the dermal hypervasculature that feeds psoriasis
Other treatable indications
The patient consultation, management, and financial modeling
source
